Evidence map›Paper›PMID 28376081›Full record

ArticleBritish journal of cancer2017

Human papillomavirus 16 is an aetiological factor of scrotal cancer.

Núria Guimerà, Laia Alemany, Gordana Halec, Michael Pawlita, Gerard Vincent Wain, José Santos Salas Vailén, Jerome E Azike, David Jenkins, Silvia de Sanjosé, Wim Quint and 1 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 6 countries.

Núria GuimeràResearch and Development, DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Laia AlemanyInfections and Cancer Unit, IDIBELL, Institut Català d'Oncologia-Catalan Institute of Oncology, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain.
Gordana HalecDivision of Genome Modifications and Carcinogenesis, Infections and Cancer Program, German Cancer Research Center, Heidelberg, Germany.
Michael PawlitaDivision of Genome Modifications and Carcinogenesis, Infections and Cancer Program, German Cancer Research Center, Heidelberg, Germany.
Gerard Vincent WainGynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
José Santos Salas VailénDepartment of Pathology, Hospital de León, León, Spain.
Jerome E AzikeDepartment of Surgery, College of Medicine, Imo State University Teaching Hospital, Orlu Campus, Orlu, Nigeria.
David JenkinsResearch and Development, DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Silvia de SanjoséInfections and Cancer Unit, IDIBELL, Institut Català d'Oncologia-Catalan Institute of Oncology, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain.
Wim QuintResearch and Development, DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
F Xavier BoschResearch and Development, DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
DDL Diagnostic Laboratory · NLAPLA Health · USCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESHeidelberg University · DEHospital de León · ESImo State University Teaching Hospital · NGInstitut d'Investigació Biomédica de Bellvitge · ESWestmead Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSquamous cell scrotal carcinoma (SCSC) is an infrequent skin cancer associated historically with occupational carcinogens. Human papillomavirus (HPV) DNA has been associated with SCSC but there is no definitive proof of its oncogenic role.

methodsHuman papillomavirus-DNA and -E6*I mRNA were analysed in six invasive histologically typed SCSC. LCM-PCR was used to localise HPV DNA to tumour cells. P16

resultsIn three warty or basaloid SCSC HPV16-DNA and E6*I-mRNA were detected. LCM-PCR confirmed HPV16 was in p16

conclusionsHuman papillomavirus 16 was present in tumour cells and oncogenically active in basaloid and warty SCSC, whereas usual SCSC was HPV-negative and showed immunostaining, suggesting p53 mutation. The dual pathways of oncogenesis and relation between histological type of SCSC and HPV are similar to that in penile cancers.

Indexed as

AdultAgedCarcinoma, Squamous CellCyclin-Dependent Kinase Inhibitor p16DNA, ViralGene Expression Regulation, NeoplasticHuman papillomavirus 16HumansMaleMiddle AgedMutationOncogene Proteins, ViralPapillomavirus InfectionsPenile NeoplasmsRepressor ProteinsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16DNA, ViralE6 protein, Human papillomavirus type 16Oncogene Proteins, ViralRepressor ProteinsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28376081
PMCPMC5418448
OpenAlexW2604881260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.